Financial News
Century Therapeutics, Inc. - Common Stock (NQ:IPSC)
2.225
-0.145
(-6.12%)
Streaming Delayed Price
Updated: 3:56 PM EDT, Mar 24, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,042,238 |
| Open | 2.370 |
| Bid (Size) | 2.220 (4,700) |
| Ask (Size) | 2.230 (3,000) |
| Prev. Close | 2.370 |
| Today's Range | 2.155 - 2.370 |
| 52wk Range | 0.3418 - 3.040 |
| Shares Outstanding | 85,029,042 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Here are the top movers in Thursday's session. ↗
January 08, 2026
These stocks are gapping in today's session ↗
January 08, 2026
Century Reports Flat Loss in Fiscal Q2 ↗
August 14, 2025
Monday's after hours session: top gainers and losers ↗
July 07, 2025
Frequently Asked Questions
Is Century Therapeutics, Inc. - Common Stock publicly traded?
Yes, Century Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Century Therapeutics, Inc. - Common Stock trade on?
Century Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Century Therapeutics, Inc. - Common Stock?
The ticker symbol for Century Therapeutics, Inc. - Common Stock is IPSC on the Nasdaq Stock Market
What is the current price of Century Therapeutics, Inc. - Common Stock?
The current price of Century Therapeutics, Inc. - Common Stock is 2.225
When was Century Therapeutics, Inc. - Common Stock last traded?
The last trade of Century Therapeutics, Inc. - Common Stock was at 03/24/26 03:56 PM ET
What is the market capitalization of Century Therapeutics, Inc. - Common Stock?
The market capitalization of Century Therapeutics, Inc. - Common Stock is 189.19M
How many shares of Century Therapeutics, Inc. - Common Stock are outstanding?
Century Therapeutics, Inc. - Common Stock has 189M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
